<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />


<meta name="author" content="Andrew Mertens" />

<meta name="date" content="2025-05-01" />

<title>Interpretation of Findings and Reporting</title>

<script src="site_libs/header-attrs-2.29/header-attrs.js"></script>
<script src="site_libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="site_libs/bootstrap-3.3.5/css/cosmo.min.css" rel="stylesheet" />
<script src="site_libs/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="site_libs/navigation-1.1/tabsets.js"></script>
<link href="site_libs/highlightjs-9.12.0/textmate.css" rel="stylesheet" />
<script src="site_libs/highlightjs-9.12.0/highlight.js"></script>

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>

<style type="text/css">code{white-space: pre;}</style>
<script type="text/javascript">
if (window.hljs) {
  hljs.configure({languages: []});
  hljs.initHighlightingOnLoad();
  if (document.readyState && document.readyState === "complete") {
    window.setTimeout(function() { hljs.initHighlighting(); }, 0);
  }
}
</script>









<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
details > summary > p:only-child {
  display: inline;
}
pre code {
  padding: 0;
}
</style>


<style type="text/css">
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #adb5bd;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script type="text/javascript">
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark the anchor link active (and if it's in a dropdown, also mark that active)
  var dropdown = menuAnchor.closest('li.dropdown');
  if (window.bootstrap) { // Bootstrap 4+
    menuAnchor.addClass('active');
    dropdown.find('> .dropdown-toggle').addClass('active');
  } else { // Bootstrap 3
    menuAnchor.parent().addClass('active');
    dropdown.addClass('active');
  }

  // Navbar adjustments
  var navHeight = $(".navbar").first().height() + 15;
  var style = document.createElement('style');
  var pt = "padding-top: " + navHeight + "px; ";
  var mt = "margin-top: -" + navHeight + "px; ";
  var css = "";
  // offset scroll position for anchor links (for fixed navbar)
  for (var i = 1; i <= 6; i++) {
    css += ".section h" + i + "{ " + pt + mt + "}\n";
  }
  style.innerHTML = "body {" + pt + "padding-bottom: 40px; }\n" + css;
  document.head.appendChild(style);
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before, .tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "\e259";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "\e258";
  font-family: 'Glyphicons Halflings';
  border: none;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->




</head>

<body>


<div class="container-fluid main-container">




<div class="navbar navbar-default  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">HOME</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="step1v2.html">Roadmap step 1-alt</a>
</li>
<li>
  <a href="step1.html">Roadmap step 1</a>
</li>
<li>
  <a href="step2.html">Roadmap step 2</a>
</li>
<li>
  <a href="step3.html">Roadmap step 3</a>
</li>
<li>
  <a href="step4.html">Roadmap step 4</a>
</li>
<li>
  <a href="step5.html">Roadmap step 5</a>
</li>
<li>
  <a href="RWE_tutorial.html">Introduction: TL Roadmap in RWE</a>
</li>
<li>
  <a href="case_study_AKI.html">Case study intro: Hep. C and AKI</a>
</li>
<li>
  <a href="PS_analysis.html">Propensity score matching analysis</a>
</li>
<li>
  <a href="TMLE_analysisV4.html">Targeted learning analysis4</a>
</li>
<li>
  <a href="appendix.html">Appendix</a>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div id="header">



<h1 class="title toc-ignore">Interpretation of Findings and
Reporting</h1>
<h4 class="author">Andrew Mertens</h4>
<h4 class="date">2025-05-01</h4>

</div>


<div id="interpretation-of-findings-and-reporting"
class="section level1">
<h1>5 Interpretation of Findings and Reporting</h1>
<p>After completing estimation (Step 3) and sensitivity analyses (Step
4), the final step involves clearly interpreting results and
transparently reporting findings. Here we integrate primary TMLE
results, assess sensitivity analyses, and discuss implications for
clinical practice, policy, and future research. ## 5.1 Integrating
Primary Results ### Primary Causal Effect Estimate (TMLE) Our primary
analysis used Targeted Maximum Likelihood Estimation (TMLE) with Super
Learner, estimating the causal effect of initiating a
sofosbuvir-containing (SOF) regimen versus a non-SOF regimen on the
90-day risk of acute kidney injury (AKI): - <strong>Risk difference
(RD):</strong> Absolute change in AKI risk attributable to SOF
initiation. - <strong>Risk ratio (RR):</strong> Relative change in AKI
risk comparing SOF initiation to non-SOF. $$${r
primary-results-placeholder, eval=FALSE} # Replace with your actual TMLE
results: # RD: 0.02 (95% CI: 0.01, 0.03); RR: 1.5 (95% CI: 1.2, 1.9)
Interpretation of Primary Results A positive risk difference (RD)
indicates an increased absolute risk of AKI from initiating a
SOF-containing regimen.</p>
<p>A risk ratio (RR) greater than 1 suggests relative harm associated
with SOF compared to non-SOF regimens.</p>
<p>Example interpretation:</p>
<p>“Initiating SOF was associated with an estimated absolute increase in
90-day AKI risk of 2% (95% CI: 1%, 3%) compared to non-SOF regimens,
translating to a 50% relative increase.”</p>
<p>5.2 Evaluating Sensitivity Analysis Results Sensitivity analyses
(Step 4) evaluated robustness of results to assumptions about
positivity, unmeasured confounding, censoring, measurement error, and
model specification.</p>
<p>Sensitivity analysis Concern addressed Potential influence on
interpretation Positivity analysis Poor overlap Check whether results
differ in high-overlap regions Unmeasured confounding (E-value) Residual
bias from confounders Evaluate E-value: large E-value supports
robustness Negative control outcome Residual confounding No association
suggests minimal residual bias IPCW censoring Informative censoring
Similar IPCW results indicate robustness Measurement error Outcome
definition accuracy Consistency across definitions suggests robust
findings Alternative SL models Model misspecification Similar results
suggest robustness to modeling decisions</p>
<p>Discuss clearly how each sensitivity result impacts confidence in the
primary finding:</p>
<p>If estimates remain consistent across sensitivity analyses, this
increases confidence in the primary causal interpretation.</p>
<p>If estimates differ notably under sensitivity conditions, explicitly
acknowledge potential biases or limitations.</p>
<p>5.3 Clinical and Regulatory Implications Clearly communicate how
findings inform clinical and regulatory decisions:</p>
<p>Clinical impact: If a significant safety signal is detected,
clinicians might consider alternative DAAs or increased renal
monitoring.</p>
<p>Regulatory impact: Findings may inform FDA labeling, safety
communications, or further post-marketing studies.</p>
<p>Example summary for stakeholders:</p>
<p>“The observed association between SOF and increased AKI risk suggests
clinicians should closely monitor renal function during initial
treatment weeks. Regulators may consider updating safety labeling or
recommending enhanced renal surveillance protocols.”</p>
<p>5.4 Limitations of the Study Explicitly address limitations to ensure
transparency:</p>
<p>Observational design: Despite advanced methods, residual unmeasured
confounding can never be completely ruled out.</p>
<p>Measurement error: Claims-based AKI outcomes might misclassify true
renal events; sensitivity analyses help mitigate this concern.</p>
<p>Generalizability: The studied population (commercially insured) may
differ from other populations (e.g., uninsured, Medicaid).</p>
<p>5.5 Recommendations for Future Research Outline clear directions for
additional research informed by the current analysis:</p>
<p>Validation studies: Replicate findings in external populations or
using clinical registries to confirm robustness.</p>
<p>Mechanistic studies: Explore biological mechanisms underlying
observed renal toxicity.</p>
<p>Additional safety studies: Extend observation windows beyond 90 days,
evaluating long-term renal outcomes.</p>
<p>5.6 Transparent Reporting and Communication Adopt transparent
reporting standards to facilitate stakeholder understanding and
regulatory compliance:</p>
<p>Follow reporting guidelines: Utilize standards like STROBE or ICH
E9(R1) guidance.</p>
<p>Share code and analytic pipeline: Ensuring reproducibility and
transparency of analyses (e.g., via GitHub repositories).</p>
<p>Example Reporting Template Population studied: U.S. adults 18–79
years, commercially insured, initiating DAA therapy for chronic HCV.</p>
<p>Treatment contrast: SOF-containing vs. non-SOF regimens.</p>
<p>Primary outcome: AKI diagnosis within 90 days.</p>
<p>Estimand: As-treated, censor-at-switch estimand.</p>
<p>Methodology: TMLE with Super Learner ensemble.</p>
<p>Primary Results: Clearly present RD, RR, confidence intervals.</p>
<p>Sensitivity Results: Clearly state implications on robustness.</p>
<p>Clinical &amp; Regulatory implications: Direct recommendations based
on findings.</p>
<p>Limitations and Future Directions: Transparent acknowledgment and
clear next steps.</p>
<p>Fit-for-purpose Checklist: Encourages explicitly checking data
quality and completeness (e.g., pharmacy claims, baseline eGFR from
electronic health records (EHR), and validated ICD codes for
outcomes).</p>
<p>Transparent Reporting Templates: RoadmapV2 emphasizes structured
reporting aligned with regulatory guidelines (ICH E9 R1), including
detailed documentation of all modeling decisions, sensitivity analyses,
and diagnostics clearly and transparently.</p>
<p>5.7 Final Conclusions Provide a concise and clear statement
summarizing key findings and their clinical, policy, and methodological
implications.</p>
<p>Example final summary:</p>
<p>“This analysis using robust causal inference methods found a
clinically meaningful and statistically significant increased risk of
AKI within 90 days associated with SOF-containing DAA regimens. Results
were robust across multiple sensitivity analyses. Clinicians and
regulators should consider these findings to guide patient monitoring
and inform safety communications. Future research should confirm these
findings externally and further explore potential underlying
mechanisms.”</p>
</div>




</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
